IQVIA urges early clinical insight in drug discovery to boost patient benefit

IQVIA Laboratories' leaders argue that drug discovery and clinical development should be linked early to improve patient outcomes.

They explain that decisions made during discovery affect later clinical success, and integrating clinical thinking can help prioritize safer, more effective candidates.

The discussion highlights the use of New Approach Methodologies (NAMs) and human-relevant science to raise the probability of success and curb rising development costs.

IQVIA offers an integrated service that combines clinical insight with discovery expertise to guide clients toward better-informed candidate choices.